Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar:104:649-654.
doi: 10.1016/j.ijid.2021.01.018. Epub 2021 Jan 11.

Impact of reproduction number on the multiwave spreading dynamics of COVID-19 with temporary immunity: A mathematical model

Affiliations

Impact of reproduction number on the multiwave spreading dynamics of COVID-19 with temporary immunity: A mathematical model

B Shayak et al. Int J Infect Dis. 2021 Mar.

Abstract

Objectives: The recent discoveries of phylogenetically confirmed COVID-19 reinfection cases worldwide, together with studies suggesting that antibody titres decrease over time, raise the question of what course the epidemic trajectories may take if immunity were really to be temporary in a significant fraction of the population. The objective of this study is to obtain an answer for this important question.

Methods: We construct a ground-up delay differential equation model tailored to incorporate different types of immune response. We considered two immune responses: (a) short-lived immunity of all types, and (b) short-lived sterilizing immunity with durable severity-reducing immunity.

Results: Multiple wave solutions to the model are manifest for intermediate values of the reproduction number R; interestingly, for sufficiently low as well as sufficiently high R, we find conventional single-wave solutions despite temporary immunity.

Conclusions: The versatility of our model, and its very modest demands on computational resources, ensure that a set of disease trajectories can be computed virtually on the same day that a new and relevant immune response study is released. Our work can also be used to analyse the disease dynamics after a vaccine is certified for use and information regarding its immune response becomes available.

Keywords: COVID-19 reinfection; Multiple wave solutions; SEIRS-type delay model; Simple and complex immune response.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
City A eliminated the epidemic via non-pharmaceutical interventions alone.
Figure 2
Figure 2
City C reached herd immunity well before the 200-day mark. ‘k’ Denotes thousand and ‘L’ denotes hundred thousand.
Figure 3
Figure 3
City B1 (we used B2 to denote the same city with a complex immune response) was a less effective form of A and had multiple waves of COVID-19. ‘k’ Denotes thousand and ‘L’ denotes hundred thousand. We stopped the simulation at 1400 days but it is important to note that the waves persisted after this time.
Figure 4
Figure 4
City F took a bold approach and “beat the virus to the finish line”. ‘k’ Denotes thousand and ‘L’ denotes hundred thousand.
Figure 5
Figure 5
City G1 represents a failed version of City F; the error in this case carries a significant price. ‘k’ Denotes thousand and ‘L’denotes hundred thousand.
Figure 6
Figure 6
City B with a complex immune response. ‘k’ Denotes thousand and ‘L’ denotes hundred thousand. W/7 denotes the weekly increments in cases scaled down by 7 as described previously, while HVF and LVF refer to the higher and lower virulence forms of the disease, respectively. y Is shown in blue, y˙ in green, z in red, z˙ in magenta, and the epi-curves in grey for y and cyan for z.
Figure 7
Figure 7
City G with a complex immune response. In the right third of the plot, the cyan bars obscure the smaller grey bars; the latter are enveloped by the green curve which is still visible. ‘k’ Denotes thousand and ‘L’ denotes hundred thousand. W/7 denotes the weekly increments in cases scaled down by 7 as described previously, while HVF and LVF refer to the higher and lower virulence forms of the disease, respectively.

References

    1. Abu-Raddad L.J., Chemaitelly H., Ayoub H.H., Al Kanaani Z., Al Khal A., Al Kuwari E. Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting. MedRxiv. 2020 https://www.medrxiv.org/content/10.1101/2020.08.24.20179457v1 Available at: - DOI
    1. Ackerly D.C. Vox; 2020. My patient caught Covid-19 twice. So long to herd immunity hopes?https://www.vox.com/2020/7/12/21321653/getting-covid-19-twice-reinfectio... Available at:
    1. Anna F., Goyard S., Lalanne A.I., Nevo F., Gransagne M., Souque P. High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris. MedRxiv. 2020 https://www.medrxiv.org/content/10.1101/2020.10.25.20219030v1 Available at: - DOI - PMC - PubMed
    1. Bjørnstad O., Shea K., Krzywinski M., Altman N. The SEIRS model for infectious disease dynamics. Nat Methods. 2020;17(6):557–558. - PubMed
    1. CGTN . 2020. Ecuador confirms first case of COVID-19 reinfection.https://news.cgtn.com/news/2020-08-30/Ecuador-confirms-first-case-of-COV... Available from: